In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is moving to an online platform or postponing all meetings and events intended to be held in person through April 30, 2020. Please check here for more information, including Academy programs on COVID-19, and links to the latest advisories from public health officials.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.


Special Issue: Annals Reports

Edited by

Annals of the New York Academy of Sciences editorial staff

Special Issue: Annals Reports

Published: July 2016

Volume 1375

Published since 1824, Annals of the New York Academy of Sciences is the Academy’s premier scientific publication.

Learn More

This issue presents a meeting report stemming from the conference “Mobile Health: The Power of Wearables, Sensors, and Apps to Transform Clinical Trials,” sponsored by the New York Academy of Sciences and Medidata Solutions on September 30 and October 1, 2015 in New York City. In addition, five original research articles in this issue discuss (1) cognitive functions in adults with β-thalassemia major: before and after blood transfusion and comparison with healthy controls; (2) musical cognition in Alzheimer’s disease: application of the Montreal Battery of Evaluation of Amusia; (3) thrombopoietin-induced hematopoiesis from mouse embryonic stem cells via hypoxia-inducible factor 1α (HIF-1α)–dependent activation of a bone morphogenetic protein 4 (BMP4) autoregulatory loop; (4) mechanisms through which deferoxamine ameliorates hepatosteatosis in ob/ob mice; and (5) evidence from an observational study showing that resting in darkness improves downbeat nystagmus.